Delivery Order SPE2DB25D3012-SPE2DB25FXABM
- Not listed
- The Defense Logistics Agency awarded a $2,030.80 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lidocaine 2% Viscous in 15 ML cup unit dose format. This non-set-aside, firm fixed price contract is scheduled for completion by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award is for the delivery of Lidocaine 2% Viscous 15 ML cups to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, the prime contractor. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $8,353.39 and an ultimate completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 40 mg/2 mL vials on August 14, 2025, with a ceiling value of $9,369.36 and firm fixed pricing. This non-set-aside, competitively awarded contract is classified as a delivery order with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform under this award at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.58 to AmerisourceBergen Drug Corp for the supply of Lidocaine 2% Viscous Solution in 100ml quantities. This contract, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was competitively executed and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 2% Viscous Solution 100ML under a firm fixed-price contract valued at $6,361.57. The contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,564,313,846 units of Lidocaine 2% Viscous 15 ML Cup. The contract has a firm-fixed price of $1,175.73 and a completion date of April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 2% Viscous 15 ML Cup UD 15ML, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $1,684.84. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine HCL 2% 200 mg/10 mL vials totaling $3,408.68 with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 100 mg/5 mL vials, with a contract ceiling value of $1,097.24. The award was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $3,889.21 to Amerisourcebergen Drug Corp, a wholly owned subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4564133886 - Lidocaine 2% Viscous Solution 100ML, with a period of performance through April 2, 2024. This delivery order is issued under a single-award indefinite delivery contract (IDC) held...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXABMDelivery Order
This delivery order, awarded September 15, 2025, provides Lidocaine 2% Viscous in 15 mL unit dose cups to the Defense Logistics Agency (DLA) with a ceiling value of $1,667.77 and firm fixed pricing. The contract is not set-aside and was competitively awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will be completed by September 16, 2025, reflecting the expedited nature of this medical supply delivery order. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this vehicle, AmerisourceBergen Drug Corp provides critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/15/25 |